Quick Takeaways
- RTW INVESTMENTS, LP filed SCHEDULE 13G/A for Axsome Therapeutics, Inc. Common Stock, $0.0001 par value per share (AXSM).
- Disclosed ownership: 3.1%.
- Date of event: 30 Jun 2025.
RTW INVESTMENTS, LP - 30 Jun 2025 SCHEDULE 13G/A Report for Axsome Therapeutics, Inc. Common Stock, $0.0001 par value per share (AXSM)
- Filing Manager
- RTW INVESTMENTS, LP
- Reporting Manager
- RTW Investments, LP
- Symbol
- AXSM
- Shares outstanding
- 48,932,355 shares
- Disclosed Ownership
- 1,516,903 shares
- Ownership
- 3.1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Aug 2025, 08:02:41 UTC
- Date of event
- 30 Jun 2025
- Previous filing
- 15 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"RTW INVESTMENTS, LP disclosed 3.1% ownership in Axsome Therapeutics, Inc. Common Stock, $0.0001 par value per share (AXSM) on 30 Jun 2025."
What Changed
- Previous schedule filing date: 15 May 2025.
- Current filing was accepted on 14 Aug 2025, 08:02.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| RTW Investments, LP | 3.1% | 1,516,903 | 0 | 1,516,903 | /s/ Roderick Wong, M.D. | Roderick Wong, M.D., Managing Partner | |
| Roderick Wong | 3.1% | 1,516,903 | 0 | 1,516,903 | s/ Roderick Wong, M.D. | Roderick Wong, M.D. |